统计显著性与分类准确率：蛋白质组数据模型构建与特征筛选疑问

Hey Arnold, great question—this is a super common (and critical) dilemma in omics-based classification, where you don’t just want features that perform well in a model, but ones that also hold statistical and biological meaning. Let’s break down practical, actionable approaches to bridge statistical significance and classification accuracy for your protein dataset:

Since you only have 40 proteins (a relatively small set for omics), you can first filter out features with no meaningful statistical difference between your case/control groups to reduce noise before building models:

• For continuous protein expression data, use t-tests (if your data follows a normal distribution) or Mann-Whitney U tests (better for non-normal omics data) to calculate p-values for each protein's difference between groups.
• Apply multiple testing correction (Bonferroni or Benjamini-Hochberg FDR) to avoid false positives. Keep only proteins with corrected p-values < 0.05 as your initial candidate pool—this weeds out features that don’t have a statistically detectable association with your outcome, so your downstream models focus on meaningful signals.

You’re already using L1/L2 and elastic net—now you can validate their selected features against statistical significance to ensure robustness:

• Extract feature importance scores from your regularization models (e.g., absolute coefficient values for elastic net).
• Take the intersection of top-ranked features from the model and the statistically significant features from step 1. This ensures you’re keeping features that both drive classification performance and show clear group differences.
• Try Stability Selection: This extends regularization by training models on multiple bootstrap resamples of your data, then counting how often each feature is selected. Combine this with your univariate significance results—prioritize features that are both frequently selected (stable) and statistically significant. This drastically reduces overfitting risk and ensures your features aren’t just artifacts of one dataset split.

If you want to directly optimize for both metrics, modify your model training to include statistical significance as a constraint or penalty:

• Weighted Loss Functions: Adjust your elastic net loss to penalize features with weak statistical significance. For example:

  Loss = Binary Cross-Entropy + α*(L1 Penalty) + β*(L2 Penalty) + γ*(p-value Penalty)
  

  Here, γ controls how heavily you penalize features with high corrected p-values (e.g., scale the penalty to be proportional to the p-value). This pushes the model to prioritize features that are both good predictors and statistically meaningful.
• Multi-Objective Optimization: Use algorithms like genetic algorithms or particle swarm optimization to optimize two goals simultaneously: classification performance (e.g., AUC-ROC, F1-score) and statistical significance (e.g., negative log of corrected p-values). This will give you a set of Pareto-optimal feature subsets—you can pick the one that balances performance and significance based on your research priorities.

Finally, don’t skip validation and biological interpretation to ensure your results are trustworthy:

• Use stratified cross-validation (to preserve case/control ratios in each fold) to test how stable your selected features are across different data splits. If a feature only shows up in one fold, it’s likely not reliable.
• For your final feature subset, run functional enrichment analysis (e.g., GO term or KEGG pathway enrichment) to check if the proteins cluster into meaningful biological pathways. This adds a layer of validation beyond just stats and model performance—after all, you want your features to make sense in the context of disease biology.

内容的提问来源于stack exchange，提问作者Arnold Klein